MMP9 and intracranial hemorrhage: The upregulation of MMP-9 could cause anti-Aβ immunotherapy to result in brain hemorrhages, which in turn contribute to the breakdown of the blood-brain barrier (BBB) [27,28,29], while the downregulation of activity and/or expression of MMP-9 could facilitate Aβ elimination across the BBB [30].